ScholarLens Back to search
2000•Chinese Journal of New Drugs and Clinical RemediesRequires access

Cost-effectiveness analysis of cefepime vs ceftazidime in treatment of pneumonia

Xiang Li

Open publisher page 0 citations

Abstract

AIM: To compare the efficacy and cost of cefepime vs ceftazidime in treating moderate severe pneumonia. METHODS: Fifty six patients were randomly divided into 2 groups. Twenty eight patients (M 26, F 2; age 79 a± s 6 a) were treated with cefepime 1.0 g iv, gtt, bid, for 7-10 d. Another twenty eight patients (M 25,F 3;age 78 a±4 a) were treated with ceftazidime 1.0 g iv, gtt, tid, for 7-10 d. RESULTS: The clinical effective rates of cefepime and ceftazidime were similar, 96% vs 93% respectively ( P 0.05), but the cost for ceftazidime was higher than that for cefepime 6924 Yuan±702 Yuan vs 5504 Yuan±615 Yuan, ( P 0.05). CONCLUSION: The ceftazidime has similar effect to cefepime, but its cost is higher.

About this research paper

What this paper is about

AIM: To compare the efficacy and cost of cefepime vs ceftazidime in treating moderate severe pneumonia. METHODS: Fifty six patients were randomly divided into 2 groups. Twenty eight patients (M 26, F 2; age 79 a± s 6 a) were treated with cefepime 1.0 g iv, gtt, bid, for 7-10 d. Another twenty eight patients (M 25,F 3;age 78 a±4 a) were treated with ceftazidime 1.0 g iv, gtt, tid, for 7-10 d. RESULTS: The clinical effective rates of cefepime and ceftazidime were similar, 96% vs 93% respectively ( P 0.05), but the cost for ceftazidime was higher than that for cefepime 6924 Yuan±702 Yuan vs 5504 Yuan±615 Yuan, ( P 0.05). CONCLUSION: The ceftazidime has similar effect to cefepime, but its cost is higher.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To compare the efficacy and cost of cefepime vs ceftazidime in treating moderate severe pneumonia. METHODS: Fifty six patients were randomly divided into 2 groups. Twenty eight patients (M 26, F 2; age 79 a± s 6 a) were treated with cefepime 1.0 g iv, gtt, bid, for 7-10 d. Another twenty eight patients (M 25,F 3;age 78 a±4 a) were treated with ceftazidime 1.0 g iv, gtt, tid, for 7-10 d. RESULTS: The clinical effective rates of cefepime and ceftazidime were similar, 96% vs 93% respectively ( P 0.05), but the cost for ceftazidime was higher than that for cefepime 6924 Yuan±702 Yuan vs 5504 Yuan±615 Yuan, ( P 0.05). CONCLUSION: The ceftazidime has similar effect to cefepime, but its cost is higher.

Key concepts: Cefepime, Ceftazidime, Medicine, Pneumonia, Internal medicine, Gastroenterology, Biology, Bacteria

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Cost-effectiveness analysis of cefepime vs ceftazidime in treatment of pneumonia — Research Paper | ScholarLens